share_log

NexImmune | 8-K: Current report

NexImmune | 8-K: Current report

NexImmune | 8-K:重大事件
美股SEC公告 ·  07/11 15:13
Moomoo AI 已提取核心訊息
NexImmune, Inc. has been notified by Nasdaq that its shares will be delisted from the Nasdaq Capital Market due to the company being identified as a 'public shell.' The delisting notice, dated July 10, 2024, follows a previous warning from December 1, 2023, and a hearing held on February 29, 2024, where NexImmune was granted an exception until May 28, 2024, to comply with listing rules. Trading of NexImmune's common stock is set to be suspended on July 12, 2024. Concurrently, NexImmune convened a special meeting of stockholders on July 11, 2024, to approve the liquidation and dissolution of the company, which was adjourned without resolution. The meeting is rescheduled for July 19, 2024, to allow the company time to explore alternative strategies to maximize asset value. The company continues to solicit votes from stockholders for the upcoming reconvened meeting.
NexImmune, Inc. has been notified by Nasdaq that its shares will be delisted from the Nasdaq Capital Market due to the company being identified as a 'public shell.' The delisting notice, dated July 10, 2024, follows a previous warning from December 1, 2023, and a hearing held on February 29, 2024, where NexImmune was granted an exception until May 28, 2024, to comply with listing rules. Trading of NexImmune's common stock is set to be suspended on July 12, 2024. Concurrently, NexImmune convened a special meeting of stockholders on July 11, 2024, to approve the liquidation and dissolution of the company, which was adjourned without resolution. The meeting is rescheduled for July 19, 2024, to allow the company time to explore alternative strategies to maximize asset value. The company continues to solicit votes from stockholders for the upcoming reconvened meeting.
NexImmune公司已收到納斯達克的通知,由於該公司被確定爲“公共外殼公司”,其股票將被從納斯達克資本市場除牌。除牌通知日期爲2024年7月10日,此前於2023年12月1日發出警告,並於2024年2月29日舉行聽證會,NexImmune被授予例外期限,以便在2024年5月28日之前遵守上市規則。 NexImmune普通股的交易將於2024年7月12日暫停。同時,NexImmune於2024年7月11日召開股東特別會議,以批准公司的清算和解散,但未能獲得解決。該會議已推遲至2024年7月19日,以使該公司有時間探索最大化資產價值的替代策略。公司繼續向股東征集即將召開的重新召開會議的投票。
NexImmune公司已收到納斯達克的通知,由於該公司被確定爲“公共外殼公司”,其股票將被從納斯達克資本市場除牌。除牌通知日期爲2024年7月10日,此前於2023年12月1日發出警告,並於2024年2月29日舉行聽證會,NexImmune被授予例外期限,以便在2024年5月28日之前遵守上市規則。 NexImmune普通股的交易將於2024年7月12日暫停。同時,NexImmune於2024年7月11日召開股東特別會議,以批准公司的清算和解散,但未能獲得解決。該會議已推遲至2024年7月19日,以使該公司有時間探索最大化資產價值的替代策略。公司繼續向股東征集即將召開的重新召開會議的投票。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息